Atrial fibrillation and anticoagulation: from randomised trials to practice
- 29 May 1993
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 341 (8857), 1381-1384
- https://doi.org/10.1016/0140-6736(93)90950-l
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1992
- Predictors of Thromboembolism in Atrial Fibrillation: I. Clinical Features of Patients at RiskAnnals of Internal Medicine, 1992
- Predictors of Thromboembolism in Atrial Fibrillation: II. Echocardiographic Features of Patients at RiskAnnals of Internal Medicine, 1992
- Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillationArchives of Internal Medicine, 1991
- Canadian atrial fibrillation anticoaguiation (CAFA) studyJournal of the American College of Cardiology, 1991
- Stroke Prevention in Atrial Fibrillation Study. Final results.Circulation, 1991
- Factors relevant to preventing embolic stroke in patients with non-rheumatic atrial fibrillationJournal of Clinical Epidemiology, 1991
- The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1990
- Physician variation in anticoagulating patients with atrial fibrillation. Dartmouth Primary Care COOP ProjectArchives of Internal Medicine, 1990
- PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATIONThe Lancet, 1989